Ashton Thomas Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.34M Buy
153,986
+22,995
+18% +$1.34M 0.22% 95
2025
Q4
$7.07M Sell
130,991
-29,169
-18% -$1.4M 0.17% 129
2025
Q3
$7.22M Buy
160,160
+79,975
+100% +$3.74M 0.19% 126
2025
Q2
$3.71M Buy
80,185
+2,727
+4% +$134K 0.13% 175
2025
Q1
$4.72M Buy
77,458
+2,664
+4% +$155K 0.18% 134
2024
Q4
$4.23M Buy
74,794
+24,314
+48% +$1.36M 0.16% 147
2024
Q3
$2.61M Buy
50,480
+18,383
+57% +$862K 0.14% 178
2024
Q2
$1.33M Sell
32,097
-19,210
-37% -$860K 0.07% 258
2024
Q1
$2.78M Buy
51,307
+14,326
+39% +$730K 0.16% 160
2023
Q4
$1.9M Sell
36,981
-18,188
-33% -$955K 0.12% 199
2023
Q3
$3.2M Buy
55,169
+3,518
+7% +$216K 0.23% 122
2023
Q2
$3.3M Buy
51,651
+3,046
+6% +$204K 0.25% 108
2023
Q1
$3.37M Sell
48,605
-3,065
-6% -$216K 0.3% 88
2022
Q4
$3.72M Buy
51,670
+11,074
+27% +$835K 0.37% 70
2022
Q3
$2.89M Buy
40,596
+10,996
+37% +$798K 0.33% 88
2022
Q2
$2.28M Sell
29,600
-2,120
-7% -$161K 0.25% 114
2022
Q1
$2.32M Buy
31,720
+3,427
+12% +$230K 0.2% 136
2021
Q4
$1.76M Buy
28,293
+24,781
+706% +$1.45M 0.17% 147
2021
Q3
$208K Sell
3,512
-443
-11% -$29.2K 0.03% 350
2021
Q2
$264K Buy
3,955
+243
+7% +$15.8K 0.04% 299
2021
Q1
$234K Buy
3,712
+171
+5% +$10.6K 0.04% 278
2020
Q4
$220K Buy
+3,541
New +$218K 0.04% 283

Other funds holding BMY

Ashton Thomas Private Wealth's BMY Position: Q1 2026 in Review

Ashton Thomas Private Wealth increased its Bristol-Myers Squibb (BMY) stake by 18% in Q1 2026, buying an estimated $1.34M and bringing the position to 153,986 shares worth $9.34M. The position accounts for 0.22% of the portfolio, ranked #95.

Ashton Thomas Private Wealth first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Ashton Thomas Private Wealth held 153,986 shares of Bristol-Myers Squibb worth $9.34M as of Q1 2026.
  • Ashton Thomas Private Wealth bought 22,995 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.34M.
  • Bristol-Myers Squibb made up 0.22% of Ashton Thomas Private Wealth's portfolio in Q1 2026, its #95 holding.
  • Ashton Thomas Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2026, filed 11 May 2026.